The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.
Open accessAbstract
Clinical studies have demonstrated an impaired fibrinolytic function in patients with angiographically ascertained coronary artery disease or previous myocardial infarction. This decreased fibrinolytic function is to a major extent explained by the presence of high plasma levels of plasminogen activator inhibitor-1 (PAI-1) and is most common in patients with hyperlipoproteinemias type IIB and IV. To further investigate the association between hypertriglyceridemia and elevated plasma levels of PAI-1, cultured human umbilical vein endothelial cells were exposed to purified lipoproteins isolated from normo- and hypertriglyceridemic (NTG and HTG) individuals. We found that very low density lipoprotein (VLDL) from both NTG and HTG subjects stimulated the secretion of PAI-1 from endothelial cells in a dose-dependent manner. HTG-VLDL at a concentration of 100 micrograms/ml gave rise to a 73% increase in PAI-1 secretion as compared to control cultures, whereas NTG-VLDL only gave rise to a 30% increase (p less than 0.05), indicating that HTG-VLDL is a more potent stimulus to PAI-1 secretion than is NTG-VLDL. Experiments in which endothelial cells were exposed to VLDL subfractions indicated that large VLDL particles, in particular, induce PAI-1 release. Binding experiments demonstrated a specific cellular binding of both NTG- and HTG-VLDL to the cells, but HTG-VLDL bound about four times more effectively than NTG-VLDL. Exposure of the endothelial cells to an LDL receptor antibody was found to block 75% (p less than 0.005) of the VLDL-induced secretion of PAI-1 from the cells.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., Faire, U., Dahlén, G., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Self-citationHamsten, A., Wiman, B., de Faire, U., & Blombäck, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132501 · Cited by 1,342
Self-citationElectrophoretic separation of plasma lipoproteins in agarose gel
Noble, R. P. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42680-x · Cited by 1,307
Separation of plasma lipoproteins by density-gradient ultracentrifugation
Redgrave, T. G., Roberts, D. C. K., & West, C. E. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90488-1 · Cited by 1,107
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
(1972) · Standard Methods of Clinical Chemistry · doi:10.1016/b978-0-12-609107-6.50016-7 · Cited by 820
Declerck, P. J., De Mol, M., Alessi, M. C., Baudner, S., Pâques, E. P., Preissner, K. T., Müller-Berghaus, G., & Collen, D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37610-0 · Cited by 485
Reappraisal of the role of insulin in hypertriglyceridemia
Olefsky, J. M., Farquhar, J. W., & Reaven, G. M. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90006-0 · Cited by 482
Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
Chmielewska, J., Rånby, M., & Wiman, B. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90407-3 · Cited by 469
Self-citationvan Mourik, J. A., Lawrence, D. A., & Loskutoff, D. J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42691-3 · Cited by 450
Vague, P., Juhan-Vague, I., Aillaud, M. F., Badier, C., Viard, R., Alessi, M. C., & Collen, D. (1986) · Metabolism · doi:10.1016/0026-0495(86)90209-x · Cited by 443
Innerarity, T. L., & Mahley, R. W. (1978) · Biochemistry · doi:10.1021/bi00601a013 · Cited by 433
Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations.
Meade, T. W., Chakrabarti, R., Haines, A. P., North, W. R., & Stirling, Y. (1979) · BMJ · doi:10.1136/bmj.1.6157.153 · Cited by 410
Emeis, J. J., & Kooistra, T. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.5.1260 · Cited by 410
Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma
Kruithof, E., Tran-Thang, C., Ransijn, A., & Bachmann, F. (1984) · Blood · doi:10.1182/blood.v64.4.907.907 · Cited by 400
Colucci, M., Paramo, J. A., & Collen, D. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111777 · Cited by 390
Ny, T., Sawdey, M., Lawrence, D., Millan, J. L., & Loskutoff, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.6776 · Cited by 379
Juhan-Vague, I., Valadier, J., Alessi, M. C., Aillaud, M. F., Ansaldi, J., Philip-Joet, C., Holvoet, P., Serradimigni, A., & Collen, D. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651064 · Cited by 362
Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.
Erickson, L. A., Ginsberg, M. H., & Loskutoff, D. J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111559 · Cited by 356
Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.
Pannekoek, H., Veerman, H., Lambers, H., Diergaarde, P., Verweij, C. L., van Zonneveld, A. J., & van Mourik, J. A. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04532.x · Cited by 344
van Hinsbergh, V., Bertina, R., van Wijngaarden, A., van Tilburg, N., Emeis, J., & Haverkate, F. (1985) · Blood · doi:10.1182/blood.v65.2.444.444 · Cited by 302
Alessi, M. C., Juhan-Vague, I., Kooistra, T., Declerck, P. J., & Collen, D. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646997 · Cited by 289
HYPERTRIGLYCERIDAEMIA AND HYPERCOAGULABILITY
Simpson, H. C. R., Meade, T. W., Stirling, Y., Mann, J. I., Chakrabarti, R., & Woolf, L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91849-4 · Cited by 287
Haemostatic variables associated with diabetes and its complications.
Fuller, J. H., Keen, H., Jarrett, R. J., Omer, T., Meade, T. W., Chakrabarti, R., North, W. R., & Stirling, Y. (1979) · BMJ · doi:10.1136/bmj.2.6196.964 · Cited by 286
Plasma very low density lipoproteins contain a single molecule of apolipoprotein B
Elovson, J., Chatterton, J. E., Bell, G. T., Schumaker, V. N., Reuben, M. A., Puppione, D. L., Reeve, J. R., & Young, N. L. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38425-x · Cited by 266
Redgrave, T. G., & Carlson, L. A. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40633-9 · Cited by 256
Tobey, T. A., Greenfield, M., Kraemer, F., & Reaven, G. M. (1981) · Metabolism · doi:10.1016/0026-0495(81)90167-0 · Cited by 243
Mehta, J., Mehta, P., Lawson, D., & Saldeen, T. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80373-x · Cited by 239
Juhan-Vague, I., Vague, P., Alessi, M., Badier, C., Valadier, J., Aillaud, M.-F., & Atlan, C. (1987) · PubMed · Cited by 218
Juhan-Vague, I., Alessi, M. C., Joly, P., Thirion, X., Vague, P., Declerck, P. J., Serradimigni, A., & Collen, D. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.3.362 · Cited by 201
Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma
Wiman, B., Almquist, Å., Sigurdardottir, O., & Lindahl, T. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80999-2 · Cited by 173
Self-citationVague, P., Juhan-Vague, I., Alessi, M. C., Badier, C., & Valadier, J. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651126 · Cited by 165
Gianturco, S. H., Gotto, A. M., Hwang, S. L., Karlin, J. B., Lin, A. H., Prasad, S. C., & Bradley, W. A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32655-3 · Cited by 161
Levin, E. G., & Santell, L. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.105.6.2543 · Cited by 138
Sprengers, E. D., Princen, H. M., Kooistra, T., & van Hinsbergh, V. W. M. (1985) · PubMed · Cited by 128
Gianturco, S. H., Brown, F. B., Gotto, A. M., & Bradley, W. A. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38070-6 · Cited by 109
van Hinsbergh, V. W. M., Binnema, D. J., de Scheffer, M. A., Sprengers, E. D., Kooistra, T., & Rijken, D. C. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.4.389 · Cited by 94
Low vascular fibrinolytic activity in obesity
Almér, L., & Janzon, L. (1975) · Thrombosis Research · doi:10.1016/0049-3848(75)90021-3 · Cited by 69
Gianturco, S. H., Eskin, S. G., Navarro, L. T., Lahart, C. J., Smith, L. C., & Gotto, A. M. (1980) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(80)90061-2 · Cited by 61
Hyperlipoproteinaemia and Reduced Fibrinolytic Activity in Healthy Coronary High‐Risk Men
Andersen, P., Arnesen, H., & Hjermann, I. (1981) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1981.tb11576.x · Cited by 57
Cited by
Molecular mechanisms of fibrinolysis
Cesarman‐Maus, G., & Hajjar, K. A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05444.x · Cited by 748
Eriksson, P., Kallin, B., van 't Hooft, F. M., Båvenholm, P., & Hamsten, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1851 · Cited by 739
Self-citationCholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
Levine, G. N., Keaney, J. F., & Vita, J. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320807 · Cited by 672
Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women
Modena, M. G., Bonetti, L., Coppi, F., Bursi, F., & Rossi, R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01976-9 · Cited by 575
Dawson, S. J., Wiman, B., Hamsten, A., Green, F., Humphries, S., & Henney, A. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82047-6 · Cited by 569
Self-citation
Metadata
- Authors
- Stiko-Rahm, A., Wiman, B., Hamsten, A., & Nilsson, J.
- Venue
- Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Published
- 1990-11
- Volume
- 10
- Issue
- 6
- Pages
- 1067-1073
- ISSN
- 0276-5047 (ISSN-L)
- OpenAlex
- W2032430567
- Cited by
- 298
- References
- 40
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.